Login
Home / KNE.V : TSXV
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kane Biotech Inc.

CAD 0.03 -$0.01 (-25.00%)
TSXV · 14 Sep 2026 17:44 UTC
Previous Close
CAD 0.03
Day Range
CAD 0.03 - CAD 0.03
Year Range
CAD 0.02CAD 0.05
Market Cap
6.15M
AVG Volume
147.6K
Trailing/Forward PE
-2.05/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2026-11-26
Primary Exchange
Toronto Stock Exchange VenturesCA
Revenue (CAD)
-500K0500K1M1.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CAD)
-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CAD)
-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CAD)
-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CAD)
-3M-2M-1M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CAD)
-0.0200.020.040.0624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CAD)
-500K0500K1M1.5MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CAD)
02.5M5M7.5M10MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-3-2-1024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
-500%0%500%1000%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-1500%-1000%-500%0%500%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Book Value Per Share (CAD)
-0.08-0.06-0.04-0.02024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CAD)
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
01234med 2.01Oct 24Dec 24Feb 25Apr 25Jun 25Aug 25Sep 25
Free Cash Flow Yield
-80%-60%-40%-20%med -47.85%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0255075100med 10.63Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
050100150med 25.65Jul 20Oct 20Jan 21May 21Aug 21Dec 21Sep 23
Kane Biotech Inc.
KNE.V
Stockpicker

Video analysis: KNE.V

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KNE.V

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

globenewswire.com · 2 Sep 2026

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

WINNIPEG, Manitoba, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the "Company", "Kane" or "Kane Biotech") is pleased to announce that it has entered into a non-exclusive distribution agreement with Ontario Medical Supply Inc. ("OMS"), an Ottawa-based medical supply distributor serving the Canadian market.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.